














A case of uroseptic shock resistant to catecholamine agents that 
endotoxin absorption treatment had high effi cacy.
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【Summary】
  A 69-year-old woman was admitted ER due to high fever. She had severe hypotention resistant 
to sufficient infusion. We performed a systemic examination by CT scan and found left renal 
hydronephrosis due to incarcerated urolithiasis. We diagnosed pyonephrosis which caused severe 
septic shock. We drained pyuria in left renal pelvis immediately and inserted ureter stent. The 
treatment of antibiotics and catecholamine agents were also started. Although the general condition 
and blood pressure of this patient was going from bad to worse, polymyxin B-immobilized ﬁ ber 
therapy （PMX-DHP ） was performed. Thereafter the general condition and blood pressure 
improved. 
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入院時現症：血圧 66/32mmHg 体温 36.7度 脈
拍 88/分
入院時血液検査所見：白血球 538×102/μ
l, BUN 30mg/dl, Cr 4.36mg/dl, CRP 24.7mg/dl, 























敗 血 症 と は 感 染 症 に 起 因 し たSystemic 







2004年に、Surviving sepsis campaign guidelines 
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